Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Avi Kapoor
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) shares surged 31.4% in pre-market trading following a narrower Q4 net loss compared to the previous year. Other stocks also showed significant movement in pre-market trading, with notable gainers including Next.e.GO N.V. (NASDAQ:EGOX) and MicroAlgo Inc. (NASDAQ:MLGO), and losers such as Sintx Technologies, Inc. (NASDAQ:SINT) and Invivyd, Inc. (NASDAQ:IVVD).
March 25, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Invivyd, Inc. shares declined 14.8% in pre-market trading despite recent FDA emergency use authorization for PEMGARDA.
Despite positive news on FDA emergency use authorization, shares declined, possibly due to profit-taking after a previous surge.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Sintx Technologies, Inc. dipped 29.7% in pre-market trading following a proposed public offering of common stock.
The announcement of a public offering of common stock has led to a negative investor reaction, resulting in a significant pre-market drop.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Next.e.GO N.V. shares rose 85.8% in pre-market trading after a 22% drop on Friday.
The dramatic pre-market rise is a rebound from the previous session's significant drop, indicating a volatile but potentially lucrative investment.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Salarius Pharmaceuticals reported a narrower Q4 net loss, leading to a 31.4% surge in pre-market trading.
The significant reduction in net loss for Q4 compared to the previous year has positively impacted investor sentiment, leading to a sharp increase in pre-market trading.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100